Market Research Logo

TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review

TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

TransGenic Inc (TransGenic) is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The products and services of the company include knockout mouse and phenotype database, genetically engineered mice, custom production of knock out mouse, custom production of antibodies and proteins, drug discovery and support services, contract services for non-clinical study, mouse related products and antibody related products. The company has two fundamental technologies, namely, Exchangeable Gene-trap Method to destroy genes of a mouse and GANP Mouse to produce high-affinity antibodies. TransGenic is headquartered in Chuo-ku, Fukuoka City, Japan.

TransGenic Inc Key Recent Developments

Dec 19,2016: Patent on Antibody Against New Lung Cancer Marker and Diagnostic Application thereof has been Granted in USA
Jul 11,2016: TRANS GENIC: Patent on oxidative stress indicator mouse has been granted in Japan
Apr 27,2016: Patent on oxidative stress indicator mouse has been granted in Europe
Mar 02,2016: Patent on Organ-Humanized Mouse Technology has been Granted in Japan
Feb 09,2016: Patent on Humanized Mouse Technology has been Granted in Japan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
TransGenic Inc - Key Facts 5
TransGenic Inc - Key Employees 6
TransGenic Inc - Key Employee Biographies 7
TransGenic Inc - Major Products and Services 8
TransGenic Inc - History 9
TransGenic Inc - Company Statement 13
TransGenic Inc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
TransGenic Inc - Business Description 16
TransGenic Inc - Corporate Strategy 17
TransGenic Inc - SWOT Analysis 18
SWOT Analysis - Overview 18
TransGenic Inc - Strengths 18
TransGenic Inc - Weaknesses 19
TransGenic Inc - Opportunities 20
TransGenic Inc - Threats 21
TransGenic Inc - Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios - Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
TransGenic Inc, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Dec 19, 2016: Patent on Antibody Against New Lung Cancer Marker and Diagnostic Application thereof has been Granted in USA 32
Jul 11, 2016: TRANS GENIC: Patent on oxidative stress indicator mouse has been granted in Japan 33
Apr 27, 2016: Patent on oxidative stress indicator mouse has been granted in Europe 34
Mar 02, 2016: Patent on Organ-Humanized Mouse Technology has been Granted in Japan 35
Feb 09, 2016: Patent on Humanized Mouse Technology has been Granted in Japan 36
Section 6 – Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
TransGenic Inc, Key Facts 5
TransGenic Inc, Key Employees 6
TransGenic Inc, Key Employee Biographies 7
TransGenic Inc, Major Products and Services 8
TransGenic Inc, History 9
TransGenic Inc, Other Locations 14
TransGenic Inc, Subsidiaries 14
TransGenic Inc, Key Competitors 22
TransGenic Inc, Ratios based on current share price 23
TransGenic Inc, Annual Ratios 24
TransGenic Inc, Annual Ratios (Cont...1) 25
TransGenic Inc, Annual Ratios (Cont...2) 26
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
TransGenic Inc, Recent Deals Summary 31
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40
List of Figures
TransGenic Inc, Performance Chart (2013 - 2017) 27
TransGenic Inc, Ratio Charts 28
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 30

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report